Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis (ATOM)
This study is currently recruiting participants.
Study NCT00579956   Information provided by University of Oxford
First Received: December 18, 2007   Last Updated: June 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melioidosis
More general conditions related to this trial
Bacterial Infections
Burkholderia Infections
Gram-Negative Bacterial Infections
Interventions listed in this trial
Meropenem
Ceftazidime
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Oxford
Mahidol University
Wellcome Trust


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services